Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 40

Sort by

Sort Order Select

Journal Articles

Optimum DTT Concentration and Treatment Time for CD38 Inactivation on RBCs Analyzed By a Newly-Devised Flow Cytometric Antibody Binding Assay

Hiroaki Furumaki, MD, Akihiro Takeshita, MD PhD, Chiaki Yamada, Harumi Fujihara, Keiko Ishizuka, Hiroki Shibata, Takahito Sinba, Momoko Sunako, Naoki Nemoto, Kaede Ino, Akari Ozawa, Hiroko Watanabe, Yukako Obata, MD

Blood (2019) 134 (Supplement_1): 3692.

https://doi.org/10.1182/blood-2019-124289

Published: 2019

Journal Articles

Mutational Profiling Predicts Clinical Outcomes to Azacytidine and Low Dose Cytarabine Plus Fludarabine (FLUGA) in Elderly Acute Myeloid Leukemia Patients Enrolled in the Pethema Phase III Flugaza Trial

Blood (2019) 134 (Supplement_1): 3891.

https://doi.org/10.1182/blood-2019-127187

Published: 2019

Journal Articles

Role of Disease Modifying Treatment in the Risk of Alloimmunization in Transfused Patients with Myelodysplastic Syndromes: A Population-Based Study

Hanne Rozema, MSc, Robby Kibbelaar, Dr., Nic Veeger, Dr., Mels Hoogendoorn, Dr., Eric van Roon, Prof. Dr.

Blood (2019) 134 (Supplement_1): 4253.

https://doi.org/10.1182/blood-2019-123357

Published: 2019

Journal Articles

High Levels of APOBEC3B Gene Expression Contribute to Poor Prognosis in Multiple Myeloma Patients

Valeriy V Lyzogubov, MD PhD, Pingping Qu, Cody Ashby, PhD, Adam Rosenthal, MS, Antje Hoering, PhD, Faith E. Davies, MD, Gareth Morgan, MD, Brian A Walker, PhD

Blood (2018) 132 (Supplement 1): 3897.

https://doi.org/10.1182/blood-2018-99-117067

Published: 2018

Journal Articles

A Practical, One Clinic Visit, Population Pharmacokinetic (PK) Protocol for Generation of PK Profiles in Subjects with Severe Hemophilia a

Victor S. Blanchette, FRCP, Laura Tiseo, BSc, CCRP, David Lillicrap, MD, Shannon Jackson, MD FRCPC, Massimo Morfini, MD, Vanessa Bouskill, MN, Manuel Carcao, Margaret L. Rand, PhD, Derek Stephens, MSc, Liane Khoo, MD, Ester Zapotocka, MD, Vladimir Komrska, MD, Jan Blatny, MD PhD

Blood (2018) 132 (Supplement 1): 2480.

https://doi.org/10.1182/blood-2018-99-111024

Published: 2018

Journal Articles

M7-FLIPI Not Valid in Follicular Lymphoma Patients with First-Line Rituximab Chemo-Free Therapy

Sandra Lockmer, MD, Weicheng Ren, PhD, Bjorn Ostenstad, MD PhD, Marianne Brodtkorb, MD PhD, Björn E Wahlin, Qiang Pan-Hammarstrom, MD PhD, Eva Kimby, MD PhD

Blood (2018) 132 (Supplement 1): 4154.

https://doi.org/10.1182/blood-2018-99-117949

Published: 2018

Journal Articles

Association between Employment Status and Hospitalization of Patients with Sickle Cell Disease: A Retrospective, Observational Pilot Study

Modupe Idowu, MD, Tong Han Chung, PhD, Katherine Yu

Blood (2018) 132 (Supplement 1): 4930.

https://doi.org/10.1182/blood-2018-99-120136

Published: 2018

Journal Articles

Relationship between Non-Prescribed Drug Use and Employment Status of Patients with Sickle Cell Disease

Modupe Idowu, MD, Tong Han Chung, PhD, Katherine Yu

Blood (2018) 132 (Supplement 1): 4932.

https://doi.org/10.1182/blood-2018-99-120373

Published: 2018

Journal Articles

GVHD Is Sustained By T Cell Maintenance within Target Tissues: Insights from Clonal Tracking and Parabiosis

Faruk Sacirbegovic, PhD, Sarah T Rosenberger, MS, Daqiang Zhao, MD PhD, Matthias Günther, PhD, Martin H Oberbarnscheidt, MD PhD, Fadi G Lakkis, MD, Thomas Höfer, PhD, Warren D Shlomchik, MD

Blood (2018) 132 (Supplement 1): 809.

https://doi.org/10.1182/blood-2018-99-119134

Published: 2018

Journal Articles

Venous Thrombosis and Breast Cancer in Older Women: Racial Disparity in Risk Factors and Outcomes

Ambarina S. Faiz, MD PhD, Shuang Guo, MD, Amanda Kaveney, MD, Claire S. Philipp, MD

Blood (2017) 130 (Supplement 1): 2380.

https://doi.org/10.1182/blood.V130.Suppl_1.2380.2380

Published: 2017

Journal Articles

TCR γδ Large Granular Lymphocyte Leukemia (LGLL) Displays Features between CD8+ and CD4+ TCR αβ LGLL

Antonella Teramo, Elena Ciabatti, Giulia Tarrini, Iacopo Petrini, Gregorio Barilà, MD, Giulia Calabretto, Cristina Vicenzetto, Matteo Leoncin, MD, Anna Cabrelle, Francesco Piazza, MD, Sara Galimberti, PhD MD, Roberto Grossi, Nadia Pisanti, Gianpietro Semenzato, MD, Renato Zambello, MD

Blood (2017) 130 (Supplement 1): 5327.

https://doi.org/10.1182/blood.V130.Suppl_1.5327.5327

Published: 2017

Journal Articles

The Hospital Mortality, Cost and Length of Stay Among Hodgkin's Lymphoma and Venous Thromboembolism Patients: An Analysis from National Inpatient Sample

Qian Wang, MD MPH, Stuthi Perimbeti, MD MPH, Sridevi Rajee, MD, Yaning Zhang, MD, Yuzhou Liu, MD, Lawrence Cytryn, MD

Blood (2017) 130 (Supplement 1): 3455.

https://doi.org/10.1182/blood.V130.Suppl_1.3455.3455

Published: 2017

Journal Articles

A Novel Role for INPP4B in Haematopoiesis and Leukemia

John F. Woolley, PhD, Meong Hi Son, MD, Irakli Dzneladze, BSc, Ruijuan He, MD, Emily Mangialardi, Martino Gabra, Mark Sharobim, Mark D. Minden, MD PhD, Leonardo Salmena, PhD

Blood (2016) 128 (22): 1720.

https://doi.org/10.1182/blood.V128.22.1720.1720

Published: 2016

Journal Articles

Inflammation-Related Gene Polymorphisms Associated with Susceptibility to Primary Immune Thrombocytopenia

Ju Li, Sai Ma, Qi Feng, Ming Hou, Jun Peng

Blood (2016) 128 (22): 3737.

https://doi.org/10.1182/blood.V128.22.3737.3737

Published: 2016

Journal Articles

Bone Marrow Small Adipocytes in Acute Myeloid Leukemia Correlate with Prognosis

Wei Lu, Jun Shi, MD PhD

Blood (2016) 128 (22): 2874.

https://doi.org/10.1182/blood.V128.22.2874.2874

Published: 2016

Journal Articles

SNPs in the Promoter of the Gene Encoding Transmembrane Transporter SLC22A4 (hOCTN1) Are Significantly Associated with an Alteration of Gene Expression and with Resistance to the Imatinib Treatment in Chronic Myeloid Leukemia

Monika Jaruskova, Rajna Hercog, Nikola Curik, Vladimir Benes, Hana Klamova, Katerina Machova Polakova

Blood (2015) 126 (23): 2463.

https://doi.org/10.1182/blood.V126.23.2463.2463

Published: 2015

Journal Articles

Profiling Myelodysplastic Syndromes By Mass Cytometry Demonstrates Distinct Immunophenotypic Aberrancies in Stem and Progenitor Populations

Gregory K. Behbehani, MD PhD, Rachel Finck, B.S., Nikolay Samusik, PhD, Pier Federico Gherardini, PhD, Kunju J Sridhar, PhD, Wendy J. Fantl, PhD, Peter L. Greenberg, MD, Garry P. Nolan, PhD

Blood (2014) 124 (21): 1903.

https://doi.org/10.1182/blood.V124.21.1903.1903

Published: 2014

Journal Articles

Somatic Hypermutation and V-J Gene Usage for CLL Prognosis: Evaluating Data from Miseq NGS Vs PCR-Sanger Sequencing Approaches

Ying Huang, PhD, Kasey Hutt, PhD, Jeff Panganiban, BS, Jeffrey Edward Miller, PhD, Jordan Thornes, BS, Anna Gazzola, PhD, Pier Paolo Piccaluga, MD PhD, Michael Klass, PhD

Blood (2014) 124 (21): 3317.

https://doi.org/10.1182/blood.V124.21.3317.3317

Published: 2014

Journal Articles

High-Throughput Ig Sequencing of Paired Blood and Spleen Samples Allows a Redefinition of Memory IgM Subsets in Humans

Davide Bagnara, PhD, Margherita Squillario, David Kipling, Thierry Mora, Aleksandra Walczak, Deborah K. Dunn-Walters, Jean-Claude Weill, Claude-Agnès Reynaud

Blood (2014) 124 (21): 565.

https://doi.org/10.1182/blood.V124.21.565.565

Published: 2014

Journal Articles

The Mutatome of CBFB / MYH11- rearranged Acute Myeloid Leukemia (AML)

Sabrina Opatz, Klaus H Metzeler, MD, Tobias Herold, MD, Sebastian Vosberg, Kathrin Bräundl, Bianka Ksienzyk, Nikola P Konstandin, Christine Wang, Alexander Graf, Stefan Krebs, PhD, Helmut Blum, PhD, Stephanie Schneider, PhD, Wolfgang Hiddemann, MD, Karsten Spiekermann, MD, Stefan K Bohlander, MD, Philipp A Greif, MD

Blood (2014) 124 (21): 14.

https://doi.org/10.1182/blood.V124.21.14.14

Published: 2014

NARROW

Optimum DTT Concentration and Treatment Time for CD38 Inactivation on RBCs Analyzed By a Newly-Devised Flow Cytometric Antibody Binding Assay

Mutational Profiling Predicts Clinical Outcomes to Azacytidine and Low Dose Cytarabine Plus Fludarabine (FLUGA) in Elderly Acute Myeloid Leukemia Patients Enrolled in the Pethema Phase III Flugaza Trial

Role of Disease Modifying Treatment in the Risk of Alloimmunization in Transfused Patients with Myelodysplastic Syndromes: A Population-Based Study

High Levels of APOBEC3B Gene Expression Contribute to Poor Prognosis in Multiple Myeloma Patients

A Practical, One Clinic Visit, Population Pharmacokinetic (PK) Protocol for Generation of PK Profiles in Subjects with Severe Hemophilia a

M7-FLIPI Not Valid in Follicular Lymphoma Patients with First-Line Rituximab Chemo-Free Therapy

Association between Employment Status and Hospitalization of Patients with Sickle Cell Disease: A Retrospective, Observational Pilot Study

Relationship between Non-Prescribed Drug Use and Employment Status of Patients with Sickle Cell Disease

GVHD Is Sustained By T Cell Maintenance within Target Tissues: Insights from Clonal Tracking and Parabiosis

Venous Thrombosis and Breast Cancer in Older Women: Racial Disparity in Risk Factors and Outcomes

TCR γδ Large Granular Lymphocyte Leukemia (LGLL) Displays Features between CD8+ and CD4+ TCR αβ LGLL

The Hospital Mortality, Cost and Length of Stay Among Hodgkin's Lymphoma and Venous Thromboembolism Patients: An Analysis from National Inpatient Sample

A Novel Role for INPP4B in Haematopoiesis and Leukemia

Inflammation-Related Gene Polymorphisms Associated with Susceptibility to Primary Immune Thrombocytopenia

Bone Marrow Small Adipocytes in Acute Myeloid Leukemia Correlate with Prognosis

SNPs in the Promoter of the Gene Encoding Transmembrane Transporter SLC22A4 (hOCTN1) Are Significantly Associated with an Alteration of Gene Expression and with Resistance to the Imatinib Treatment in Chronic Myeloid Leukemia

Profiling Myelodysplastic Syndromes By Mass Cytometry Demonstrates Distinct Immunophenotypic Aberrancies in Stem and Progenitor Populations

Somatic Hypermutation and V-J Gene Usage for CLL Prognosis: Evaluating Data from Miseq NGS Vs PCR-Sanger Sequencing Approaches

High-Throughput Ig Sequencing of Paired Blood and Spleen Samples Allows a Redefinition of Memory IgM Subsets in Humans

The Mutatome of CBFB / MYH11- rearranged Acute Myeloid Leukemia (AML)

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only